Novartis AG (NVSEF)
Develops and sells medicines treating cancer, heart disease, autoimmune disorders, and rare genetic conditions
$150.00-0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+29.3%
The outlook
Novartis is trading above both its 50- and 200-day moving averages, positioned about two-thirds of the way up from its 52-week low. The stock carries a trailing P/E of 22.7, and analyst sentiment is tilted constructively based on current data.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range65% of the way from its 52-week low to high
Market cap
$285.11B
52-wk high
$171.29
52-wk low
$110.74
50-day avg
$149.21
200-day avg
$144.32
Trailing P/E
22.7